onda

News

  • EFPIA/PhRMA Joint Principles for Responsible Clinical Trials Data Sharing

    The two pharmaceutical industry bodies, European Federation of Pharmaceutical Manufacturers and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA), have published their common “Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers”
    -Read more-
  • Health Innovation Challenge Fund Call – Deadline 2 September

    The call for the Health Innovation Challenge Fund expires on 2 September 2013 and is the last chance to apply under the current areas of interest.
    -Read more-
  • UK plans to revise model agreement for university-industry collaborations

    The UK government’s Intellectual Property Office (IPO) will revise its model agreement for university–industry collaboration. The move, which comes after 8 years of implementation, is driven by evidence that the model is too restrictive and does not support open innovation.
    -Read more-
  • Artreat: A Multiscale Model For Prediction Of Atherosclerosis Progression

    On August 31st, 2013 ARTreat project (ICT-2007, FP7-224297), entitled “Multi-level patient-specific artery and atherogenesis model for outcome prediction, decision support treatment, and virtual hand-on training” successfully ended, at month 60 for the project. ARTreat is an integrated project coordinated by the National Council of Research (CNR) of Italy, managing 20 EU partners selected to provide a multidisciplinary approach (IT, biological, medical, bioengineering) to the project objectives.
    -Read more-
  • Watch the DISCIPULS interviews on YouTube

    Clinicians and key people from the DISCIPULUS project were interviewed on the Digital Patient and its place within the future healthcare. The videos are now available on The Digital Patient YouTube channel.
    -Read more-
  • Prof Viceconti releases an interview for Personal Health Foresight

    Recently Laura Pombo Juárez, Director of Impetu Solutions responsible of PHS Foresight outreach activities, interviewed Prof. Marco Viceconti, Director of the Insigneo Institute and Executive Director of the VPH Institute, on the future of personal health forecasting and in silico medicine.
    -Read more-

News

More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO